Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Spironolactone plus finasteride reduces hirsutism more effectively.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Patient had scalp allergy from minoxidil; test helped identify cause and suggest alternative treatments.

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Activating NRF2 might help treat hair disorders by improving antioxidant defenses.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Lupus can look like hair loss from alopecia areata but needs different treatment.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Active transdermal technologies in cosmetics help deliver skin treatments effectively, but their safety and effectiveness depend on skin type and treatment choice.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.